drugset / Trial / NCT01083732
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
NaSingle-groupOpen-label
Summary
To investigate the safety and tolerability of dabigatran etexilate solution in children and to obtain preliminary pharmacokinetic/pharmacodynamic data
Timeline
- Start
- 2010-03
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | — | Oral |